Muscarinic receptor-dependent activation of phospholipase C in the developing human fetal central nervous system.
The coupling of muscarinic-cholinergic receptors (mAChR) to adenylate cyclase and phospholipase C (PLC) second messenger systems has been demonstrated in many animal species. However, little is known about this association in the developing human central nervous system. Because of the proposed role of acetylcholine in the regulation of development and differentiation of neural cells, an understanding of these relationships during human fetal development gains importance. We report, in this communication, the coupling of mAChR with PLC in the human fetal brain. This coupling was determined using two independent approaches that relied upon estimating the accumulation of inositol phosphates (IPs) and cytidine diphosphate diacylglycerol (CDP-DAG). Carbachol treatment of brain slices, in the presence of lithium, resulted in the accumulation of IPs. Analysis of the kinetics of this accumulation showed that IP3 and IP2 increased rapidly, reaching a peak or plateau before IP. The results also showed that agonist-stimulated PLC produced two second messengers, IP3 and DAG. The production of DAG was strongly supported by the carbachol-dependent increase of CDP-DAG. The accumulation of IP and CDP-DAG was dependent on agonist concentration. The obtained EC50 values were approximately: carbachol 47 microM; acetylcholine 6 microM; and oxotremorine 25 microM. Unexpectedly, all three agonists demonstrated a similar efficacy. The cholinergic stimulation of inositide hydrolysis appears to be the result of activation of the m1 muscarinic receptor.
Larocca
J N
JN
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461.
Rodriguez-Gabin
A G
AG
Rashbaum
W K
WK
Weidenheim
K M
KM
Lyman
W D
WD
D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000196:embryology*; D002217:Carbachol / Q000494:pharmacology; D003567:Cytidine Diphosphate Diglycerides / Q000378:metabolism; D005314:Embryonic and Fetal Development; D004789:Enzyme Activation; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000378:metabolism; D010890:Pirenzepine / Q000494:pharmacology; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011976:Receptors, Muscarinic / Q000502:physiology*; D015290:Second Messenger Systems; D010738:Type C Phospholipases / Q000378:metabolism*
D003567:Cytidine Diphosphate Diglycerides; D007295:Inositol Phosphates; D011976:Receptors, Muscarinic; D010890:Pirenzepine; D001285:Atropine; D002217:Carbachol; D010738:Type C Phospholipases